The present study showed that mRNA expression levels of Nav1.6 and Nav1.7 were significantly upregulated in prostate cancer cells compared with those in NP or BPH samples, suggesting Nav1.6 and Nav1.7 may be potential diagnostic markers for prostate cancer. Here, SCN9A is linked to prostate carcinoma.